Toll-Like Receptor Pathways in Autoimmune Diseases (Q38357504)

2 September 2017

1 reference

title

Toll-Like Receptor Pathways in Autoimmune Diseases (English)

1 reference

2 September 2017

0 references

2

Peter Szodoray

1 reference

2 September 2017

Ji-Qing Chen

1

1 reference

PubMed ID

25687121

2 September 2017

Margit Zeher

series ordinal

3

1 reference

2 September 2017

17 February 2015

1 reference

Clinical Reviews in Allergy & Immunology

2 September 2017

1 reference

2 September 2017

50

1 reference

2 September 2017

1

1 reference

2 September 2017

1-17

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-015-8473-z

2 September 2017

0 references

cites work

TLR2 and TLR4 in autoimmune diseases: a comprehensive review

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Emerging role of endosomal toll-like receptors in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Reading the viral signature by Toll-like receptors and other pattern recognition receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

The evolution of vertebrate Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Toll-like receptors in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

IRAK: a kinase associated with the interleukin-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Regulation of TNF-alpha-mediated hyperplasia through TNF receptors, TRAFs, and NF-kappaB in synoviocytes obtained from patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Molecular basis for the unique specificity of TRAF6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Modulation of life and death by the tumor necrosis factor receptor-associated factors (TRAFs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Tumor necrosis factor receptor-associated factors (TRAFs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

A new protein containing an SH2 domain that inhibits JAK kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

A family of cytokine-inducible inhibitors of signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Structure and function of a new STAT-induced STAT inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Expression of Toll-like receptors 7, 8, and 9 in primary Sjögren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Genetic variations in Toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Polymorphisms within Toll-like receptors are associated with systemic lupus erythematosus in a cohort of Danish females

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Association study of IRAK-M and SIGIRR genes with SLE in a large European-descent population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Decreased expressions of the TNF-alpha signaling adapters in peripheral blood mononuclear cells (PBMCs) are correlated with disease activity in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Toll-like receptors modulate adult hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Extracellular GC-rich DNA activates TLR9- and NF-kB-dependent signaling pathways in human adipose-derived mesenchymal stem cells (haMSCs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Regulation of remyelination in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Initial immunopathogenesis of multiple sclerosis: innate immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

SOCS1 and SOCS3 in the control of CNS immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Identification of SOCS-3 as a potential mediator of central leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Interferon-beta inhibits Th17 cell differentiation in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Torque teno virus (TTV) in multiple sclerosis patients with different patterns of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Antimalarials in rheumatology: efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Expression of TNF-alpha and related signaling molecules in the peripheral blood mononuclear cells of rheumatoid arthritis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Investigation of association between the TRAF family genes and RA susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Systemic sclerosis (scleroderma): an integrated challenge in rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Psoriasis--epidemiology and clinical spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Comparison of expression of heat-shock protein 60, Toll-like receptors 2 and 4, and T-cell receptor gammadelta in plaque and guttate psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Innate and adaptive immunity and the pathophysiology of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

TGF-alpha regulates TLR expression and function on epidermal keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Identification of low-frequency TRAF3IP2 coding variants in psoriatic arthritis patients and functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Deficient SOCS3 and SHP-1 expression in psoriatic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Therapeutic hope for psoriasis offered by SOCS (suppressor of cytokine signaling) mimetic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well tolerated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Toll-like receptors: applications to dermatologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8473-Z

MicroRNA-mediated mechanism of vitamin D regulation of innate immune response

21 January 2018

1 reference

12 December 2020

Role of infectious agents in systemic rheumatic diseases.

1 reference

12 December 2020

Association of TLR9 gene polymorphisms with lupus nephritis in a Chinese Han population.

1 reference

12 December 2020

The expression of SOCS is altered in rheumatoid arthritis

1 reference

12 December 2020

Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis

1 reference

12 December 2020

Innate immune-related receptors in normal and psoriatic skin

1 reference

12 December 2020

Multiplex screening of 22 single-nucleotide polymorphisms in 7 Toll-like receptors: an association study in rheumatoid arthritis

1 reference

12 December 2020

TNF signaling: early events and phosphorylation.

1 reference

12 December 2020

Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin

1 reference

12 December 2020

Toll-like receptor in salivary glands from patients with Sjögren's syndrome: functional analysis by human salivary gland cell line

1 reference

12 December 2020

Statins and demyelination.

1 reference

12 December 2020

The role of anti-malarials in rheumatoid arthritis--the American experience.

1 reference

12 December 2020

Matrix metalloproteinases and their inhibitors in connective tissue remodeling

1 reference

12 December 2020

The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products

1 reference

12 December 2020

The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Association study of TLR-9 polymorphisms and systemic lupus erythematosus in northern Chinese Han population

1 reference

12 December 2020

Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma

1 reference

12 December 2020

Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis

1 reference

12 December 2020

Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus

1 reference

12 December 2020

Expression of Toll-like receptors and their signaling pathways in rheumatoid synovitis

1 reference

12 December 2020

Activation of JAK-STAT1 signal transduction pathway in lesional skin and monocytes from patients with systemic lupus erythematosus

1 reference

12 December 2020

Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis.

1 reference

12 December 2020

The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells

1 reference

12 December 2020

A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists

1 reference

12 December 2020

Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA)

1 reference

12 December 2020

Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands

1 reference

12 December 2020

Clinical aspects and treatment of systemic lupus erythematosus

1 reference

12 December 2020

Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis

1 reference

12 December 2020

10.1007/S12016-015-8473-Z

Identifiers

DOI

1 reference

PubMed ID

25687121

Dimensions Publication ID

2 September 2017

0 references

1 reference

PubMed ID

25687121